Results 301 to 310 of about 319,352 (344)

Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies

Nature Medicine, 2021
Delphine Planas, Timothée Bruel, Ludivine Grzelak   +2 more
exaly  

[Therapy of infectious intestinal diseases].

Medizinische Welt (Stuttgart, Germany : 1951), 2004
J, SEILER, C, GAEDEKE
openaire   +1 more source

Lipid nanoparticles for mRNA delivery

Nature Reviews Materials, 2021
Xucheng Hou, Robert Samuel Langer Jr, Yi-Zhou Dong   +2 more
exaly  

Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa‐associated lymphoid tissue (MALT lymphoma)

Ca-A Cancer Journal for Clinicians, 2016
Markus Raderer, Barbara Kiesewetter
exaly  

Pathophysiological basis of human papillomavirus in penile cancer: Key to prevention and delivery of more effective therapies

Ca-A Cancer Journal for Clinicians, 2016
Adam S Baumgarten, Anna R Giuliano
exaly  

The importance of immunization in cancer prevention, treatment, and survivorship

Ca-A Cancer Journal for Clinicians, 2017
Christopher R Flowers, Ted Gansler, Saad B Omer   +2 more
exaly  

Bacterial biofilms: from the Natural environment to infectious diseases

Nature Reviews Microbiology, 2004
Paul Stoodley
exaly  

Persister cells, dormancy and infectious disease

Nature Reviews Microbiology, 2006
Kim Lewis
exaly  

LPS, TLR4 and infectious disease diversity

Nature Reviews Microbiology, 2005
Samuel I Miller, Robert K Ernst
exaly  

Mathematical models of infectious disease transmission

Nature Reviews Microbiology, 2008
Nicholas C Grassly, Christophe Fraser
exaly